 |
|
HBsAg level and clinical course in patients with chronic hepatitis B treated with nucleoside analogue: five years of follow-up data
Jeong Han Kim, Yun Jung Choi, Hee Won Moon, Soon Young Ko, Won Hyeok Choe, So Young Kwon
Clin Mol Hepatol. 2013;19(4):409-416. Published online 2013 Dec 28 DOI: https://doi.org/10.3350/cmh.2013.19.4.409
|
|
Citations to this article as recorded by
 Usefulness of a Hepatitis B Surface Antigen-Based Model for the Prediction of Functional Cure in Patients with Chronic Hepatitis B Virus Infection Treated with Nucleos(t)ide Analogues: A Real-World Study
Gian Paolo Caviglia, Yulia Troshina, Enrico Garro, Marcantonio Gesualdo, Serena Aneli, Giovanni Birolo, Fabrizia Pittaluga, Rossana Cavallo, Giorgio Maria Saracco, Alessia Ciancio
Journal of Clinical Medicine.2021; 10(15): 3308. CrossRef Tenofovir Disoproxil Fumarate Monotherapy is Superior to Entecavir-Adefovir Combination Therapy in Patients with Suboptimal Response to Lamivudine-Adefovir Therapy for Nucleoside-Resistant HBV: A 96-Week Prospective Multicentre Trial
Sae Hwan Lee, Gab Jin Cheon, Hong Soo Kim, Sang Gyune Kim, Young Seok Kim, Soung Won Jeong, Jae Young Jang, Boo Sung Kim, Baek Gyu Jun, Young Don Kim, Dae Won Jun, Joo Hyun Sohn, Tae Yeob Kim, Byung Seok Lee
Antiviral Therapy.2018; 23(3): 219. CrossRef Clinical Usefulness of HBsAg Quantification in Patients with Chronic Hepatitis B Infection
Ergenekon Karagoz, Alpaslan Tanoglu
Hepatitis Monthly.2017;[Epub] CrossRef Hepatitis B s antigen kinetics during treatment with nucleos(t)ides analogues in patients with hepatitis B e antigen‐negative chronic hepatitis B
Athanasia Striki, Spilios Manolakopoulos, Melanie Deutsch, Anastasia Kourikou, George Kontos, Hariklia Kranidioti, Emilia Hadziyannis, George Papatheodoridis
Liver International.2017; 37(11): 1642. CrossRef Pronounced decline of serum HBsAg in chronic hepatitis B patients with long-term effective nucleos(t)ide analogs therapy
Meng-Lan Wang, En-Qiang Chen, Chuan-Min Tao, Tao-You Zhou, Juan Liao, Dong-Mei Zhang, Juan Wang, Hong Tang
Scandinavian Journal of Gastroenterology.2017; 52(12): 1420. CrossRef Hepatitis B surface antigen levels at 6 months after treatment can predict the efficacy of lamivudine-adefovir combination therapy in patients with lamivudine-resistant chronic hepatitis B
Jeong Han Kim, Hee Won Moon, Soon Young Ko, Won Hyeok Choe, So Young Kwon
Clinical and Molecular Hepatology.2014; 20(3): 274. CrossRef
|